Latest News

Arlo Technologies (ARLO) is back in focus after reporting quarterly results that topped analyst expectations and unveiling a US$50 million share repurchase program running through 2027, which signals management’s confidence in its services led model. See our latest analysis for Arlo Technologies. The latest results and buyback news come after a period where momentum has been building, with a 19.09% 1 month share price return and a 27.94% 1 year total shareholder return, alongside a 135.70%...

In March 2026, First Majestic Silver Corp. reported successful 2025 exploration results at its Jerritt Canyon Gold Mine in Nevada, highlighting extensive drilling across Mahala, Javelin, and Saval that identified both underground and near-surface gold zones potentially amenable to multiple mining methods. A key outcome was the recognition that earlier underground drilling at Javelin likely understated the true thickness of the mineralized zone, with new surface drilling indicating possible...

On March 11, 2026, ZTO Express cancelled 7.37 million repurchased Class A shares, trimming its total Class A share count by about 0.93%. This relatively small cancellation slightly increases each remaining shareholder’s ownership stake and underlines management’s focus on active capital management and regulatory transparency. Next, we’ll explore how this recent share cancellation, which incrementally lifts per-share ownership, may influence ZTO Express’s broader investment...

Assurant (AIZ) has drawn investor attention after reporting fourth quarter and full year 2025 results that included 17% growth in net operating income per share and 7.5% revenue growth, along with positive 2026 adjusted EBITDA guidance. See our latest analysis for Assurant. At a share price of $218.53, Assurant’s recent 1 day share price return of 1.50% comes after a softer period, with a 90 day share price return decline of 6.31%. Its 3 year total shareholder return of about 2x suggests...

Terns Pharmaceuticals recently attracted renewed attention after updating its corporate presentation with refreshed pipeline timelines and milestones, while also being selected for inclusion in a STOXX benchmark index effective March 23, 2026. This combination of clearer development visibility, impending index inclusion, and investor focus on the upcoming earnings update has sharpened debate around the company’s long-term prospects and current financial pressures. With investors now closely...

Alamos Gold (TSX:AGI) is back in focus after a 5.5% decline that coincided with a wider pullback in metals and mining stocks, following upbeat production guidance and a newly announced dividend scheduled for March 2026. See our latest analysis for Alamos Gold. The recent 5.5% pullback fits into a picture where Alamos Gold’s 1 day share price return of 4.81% and 7 day return of 7.08% come after a strong 90 day share price return of 21.9% and a very large 5 year total shareholder return. This...

Why United Community Banks Stock Is On Watch United Community Banks (UCB) has seen its share price under pressure recently, with a roughly 13% decline over the past month and about a 7% decline in the past 3 months, prompting closer investor attention. See our latest analysis for United Community Banks. That recent 13% 30 day share price pullback comes after a softer 90 day share price return of about 7% and contrasts with a 1 year total shareholder return of 8.6%. This hints that near term...

Lowe's Companies (LOW) moved into focus after strong Q4 2025 results were followed by cautious 2026 guidance, a new Neutral rating from KGI Securities, and fresh selling pressure from institutional investors. See our latest analysis for Lowe's Companies. The mixed reaction to Lowe's fourth quarter and FY 2026 outlook has coincided with a 17.33% 1 month share price decline and weaker near term momentum, even as the 1 year total shareholder return of 7.99% and 3 year total shareholder return of...

Baidu (BIDU) has drawn fresh attention after Baidu AI Cloud launched DuClaw, a zero deployment service that gives instant access to the OpenClaw agent platform and Baidu’s core information tools through a fully managed web interface. See our latest analysis for Baidu. Baidu’s DuClaw launch lands at a time when the company’s 7 day share price return of 4.22% contrasts with a 30 day share price decline of 9.44%. Over a 1 year period, the total shareholder return of 32.24% sits against a weaker...

Context for Forestar Group after recent trading moves Forestar Group (FOR) has seen mixed share performance recently, with a 1 day gain of 1.6% contrasting with declines over the past week, month, and past 3 months, which may prompt investors to reassess the stock. See our latest analysis for Forestar Group. Zooming out, Forestar Group’s recent 1 day share price gain sits against a weaker patch, with a 30 day share price return of a 16.4% decline but a 3 year total shareholder return of...

Restaurant Brands International (QSR) is back in focus after reporting earnings that exceeded analyst expectations, supported by sales growth at Tim Hortons, Burger King, and Popeyes, along with an increased dividend and active brand investment. See our latest analysis for Restaurant Brands International. The latest results and dividend increase come after a mixed few months for investors, with a 9.84% 1 month share price return helping offset earlier weakness and contributing to a 14.13% 1...

Home Bancshares stock performance snapshot Home Bancshares (HOMB) has been trading under pressure recently, with the share price around $26.31 and negative returns over the past week, month, past 3 months, year to date, and past year. At the same time, the bank reports annual revenue of about $1.07b and net income of roughly $475.44m, alongside positive multi year total returns. This presents investors with a mixed set of signals to weigh. See our latest analysis for Home Bancshares (Conway...

Earlier this month, Zealand Pharma reported positive topline Phase 2 ZUPREME-1 results showing petrelintide achieved statistically significant, clinically meaningful weight loss with tolerability similar to placebo in people living with overweight and obesity. The data suggest petrelintide’s once-weekly amylin-based profile could offer a differentiated, potentially more tolerable alternative to existing peptide weight-loss therapies, reinforcing Zealand’s obesity franchise with Roche. We’ll...

In early March 2026, Match Group, Inc. announced that the Chief Operating Officer role will be eliminated on June 2, 2026, leading long-time executive Hesam Hosseini to depart after more than 15 years with the company. This leadership change comes as analysts highlight faster product experimentation and early engagement improvements at Tinder, raising questions about how Match Group’s operating structure will support its product-led refresh. We’ll now examine how Tinder’s faster product...

TELUS Corporation recently confirmed a significant cybersecurity breach at its digital services arm, where threat actors allegedly accessed nearly 1 petabyte of customer and call data, prompting an ongoing investigation and remediation efforts. This incident highlights growing operational and reputational risks for TELUS as it expands into higher-value digital and technology services alongside its core telecom operations. We’ll now examine how this large-scale cybersecurity breach may...

MicroVision’s latest earnings draw investor focus MicroVision (MVIS) is back in the spotlight after reporting full year 2025 earnings, with sales of US$1.21 million compared with US$4.7 million a year earlier and a net loss of US$94.98 million. See our latest analysis for MicroVision. Despite the earnings update, MicroVision’s share price has faced pressure, with a 30 day share price return of 29.18% and a 1 year total shareholder return of 58.42%. This suggests momentum has been fading as...

In recent months, Haemonetics has reported a recovery in its Hospital division, underpinned by growing adoption of its FDA-approved NexSys PCS system with Persona Technology and supported by acquisitions broadening its presence in esophageal protection and interventional cardiology. An interesting angle is how this combination of higher-margin NexSys PCS usage and newly acquired hospital technologies is helping Haemonetics improve operational efficiency while deepening its role inside...

Why Lepu Biopharma’s Latest Guidance Matters Lepu Biopharma (SEHK:2157) has drawn fresh attention after issuing earnings guidance that points to at least RMB 200 million in net profit for 2025, compared with a RMB 411 million loss in 2024. The company links this projected swing to revenue from PUYOUHENG and newly approved MEIYOUHENG, expanded licensing income, and a one off reclassification gain on an investment, while an upcoming March 25 board meeting will review the full 2025 results and...

Why ServiceTitan stock is back in focus ServiceTitan (TTAN) is drawing fresh attention after a busy set of March updates, including fourth quarter and full year results, new revenue guidance, and a leadership hire focused squarely on AI. See our latest analysis for ServiceTitan. ServiceTitan shares have been volatile around the recent earnings release and AI focused leadership appointment, with a 1 day share price return of 6.41% decline and a 7 day share price return of 14.65% decline. The...

In recent weeks, Enbridge approved two large-scale U.S. renewable energy projects worth about US$1.60 billion and expanded its secured growth backlog to CA$39.00 billion, while highlighting contract-backed infrastructure, diversified operations and a multi-decade record of dividend increases in its 2026 Management Information Circular. The company is also targeting rising data-center energy demand through more than 50 prospective projects across North America, including a Texas wind...

In recent days, Alpha Metallurgical Resources director Kenneth S. Courtis has purchased multiple blocks of company stock totaling tens of thousands of shares, lifting his direct ownership to more than 866,000 shares and adding to a year-long pattern of insider buying without any reported sales. This sustained accumulation by a board member, coming shortly after a weaker fourth quarter marked by pressure on coal margins, highlights a clear alignment between leadership and shareholders at a...

If you are wondering whether STMicroelectronics is attractively priced today, this article will walk you through how its current share price stacks up against several valuation checks. The stock closed at €28.62, with returns of 5.4% over the last 7 days, 0.6% over 30 days, 22.1% year to date, 28.3% over 1 year, a 35.1% decline over 3 years and a 3.5% decline over 5 years. These figures can shape how investors see its growth potential and risk profile. Recent attention around...

On March 5, 2026, Popular, Inc. declared a monthly cash dividend of US$0.132813 per share on its 6.375% Non-Cumulative Monthly Income Preferred Stock, 2003 Series A, payable on March 31, 2026 to shareholders of record as of March 15, 2026, and earlier in the month its CEO presented at the RBC Capital Markets Global Financial Institutions Conference in New York. The combination of a continued preferred dividend payout and management’s public commentary on capital return, digital investments,...

Why RPC (RES) is on investors’ radar RPC (RES) has drawn attention after recent trading left the stock at $6.52, with returns over the past month and past 3 months outpacing its 1 day performance. Investors are weighing that shift against fundamentals. See our latest analysis for RPC. Zooming out, RPC’s 1 year total shareholder return of 26.01% alongside a 17.90% year to date share price return suggests recent momentum is building despite a softer 1 day move. If RPC’s recent run has you...